Biology, physiology, and clinical chemistry of osteocalcin

Journal of Clinical Ligand Assay

Volumn 21, Issue 2, 1998, Pages 128-138

  Gundberg, Caren M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone matrix; Gamma carboxyglutamic acid; Immunoassays; Osteocalcin; Osteoporosis; Vitamin K

Indexed keywords

4 CARBOXYGLUTAMIC ACID; OSTEOCALCIN; VITAMIN K GROUP;

ARTICLE; BONE TURNOVER; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; IMMUNOASSAY; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN STRUCTURE;

EID: 0032450721     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (112)

1. Gallop PM, Lian JB, Hauschka PV: Carboxylated calcium-binding proteins and vitamin K. New Eng J Med 1980;320:1460.
2. Hauschka PV, Carr SA: Calcium-dependent alpha-helical structure in osteocalcin. Biochem 1982;21:2538.
3. Puchacz E, Lian JB, Stein GS, et al: Chromosomal localization of the human osteocalcin gene. Endocrinology 1989;124:2648.
4. Owen TA, Bortell R, Shalhoub V, et al: Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc Natl Acad Sci USA 1993;90:1503.
5. Ozono K, Liao J, Kerner S, et al: The vitamin D-responsive element in the human osteocalcin gene. J Biol Chem 1990;265:21881.
6. Pan LC, Price PA: The propeptide of rat bone γ-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursor. Proc Natl Acad Sci USA 1985;82:6109.
7. Gundberg CM, Clough ME: The osteocalcin propeptide is not secreted in vivo or in vitro. J Bone Min Res 1992;7:73-80.
8. Hauschka PV, Gallop PM: Purification and calcium-binding properties of osteocalcin, the gamma-carboxyglutamate-containing protein of bone, in Wasserman R, et al (eds): Calcium Binding Proteins and Calcium Function. Amsterdam, Elsevier/North-Holland, 1977, p 338.
9. Hauschka PV, Reid ML: Timed appearance of a calcium-binding protein containing γ-carboxyglutamic acid in developing chick bone. Dev Biol 1978;65:426.
10. Lian JB, Roufosse AH, Reit B, et al: Concentrations of osteocalcin and phosphoprotein as a function of mineral content and age in cortical bone. Calcif Tissue Int 1982;34(S2):82.
11. Owen TA, Aronow M, Shalhoub V, et al: Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420.
12. Harris S, Enger R, Riggs B, et al: Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Min Res 1995;10:178.
13. Pockwinse SM, Lawrence JB, Singer RH, et al: Gene expression at single cell resolution associated with development of the bone cell phenotype: ultrastructural and in situ hybridization analysis. Bone 1993;14:347.
14. Gerstenfeld LC, Chipman SD, Glowacki J, et al: Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Bio 1987;122:49.
15. Gerstenfeld L, Lian J, Gotoh Y, et al: Use of cultured embryonic chicken osteoblasts as a model of cellular differentiation and bone mineralization. Conn Tissue Res 1989;21:215.
16. Zhou H, Choong P, McCarthy R, et al: In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Min Res 1994;9:1489.
17. Stein GS, Lian JB, Owen TA: Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. The FASEB 1990;J4:3111.
18. Chenu C, Colucci S, Grano M, et al: Osteocalcin induces chemotaxis, secretion of matrix proteins and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 1994;127:1149.
19. Glowacki J, Rey C, Cox K, et al: Effects of bone matrix components on osteoclast differentiation. Conn Tissue Res 1989;20:121.
20. Lian JB, Tassinari M, Glowacki J: Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest 1984;73:1223.
21. Ducy P, Desbois C, Boyce B, et al: Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448.
22. Eastell R, Delmas PD, Hodgson SF, et al: Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 1988;67:741.
23. Brown J, Malaval L, Chapuy M, et al: Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. The Lancet May 1984:1091.
24. Brown JP, Delmas PD, Arlot M, et al: Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. J Clin Endocrinol Metab 1987;64:954.
25. Charhon SA, Delmas PD, Malaval L: Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. J Clin Endocrinol Metab 1986;63:892.
26. Marie PJ, Sabbagh A, de Vernejoul M-C, et al: Osteocalcin deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab 1989;69:272.
27. Price PA, Williamson MK, Lothringer JW: Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981;256:12760.
28. Gundberg CM, Weinstein RS: Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest 1986;77:1762.
29. Power MJ, Gosling JP, Fottrell PF: Radioimmunoassay of osteocalcin with polyclonal and monoclonal antibodies. Clin Chem 1989;35:1408.
30. Farrugia W, Melick R: Metabolism of osteocalcin. Calcif Tissue Int 1986;39:234.
31. Garnero P, Grimaux M, Seguin P, et al: Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Min Res 1994;9:255.
32. Taylor AK, Linkhart S, Mohan S, et al: Multiple osteocalcin fragments in human urine and serum as detected by a midmolecule osteocalcin radioimmunoassay. J Clin Endocrinol Metab 1990;70:467.
33. Tracy RP, Andrianorivo A, Riggs BL, et al: Comparison of monoclonal and polyclonal antibody-based immunoassays forosteocalcin: a study of sources of variation in assay results. J Bone Min Res 1990;5:451.
34. Chen JT, Hosoda K, Hasumi K, et al: Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Min Res 1996;11:1784.
35. Gorai L, Hosoda K, Taguchi Y, et al: A heterogeneity in serum osteocalcin N-terminal fragments in Paget's disease: A comparison with other biochemical indices in pre-and post-menopause. J Bone Min Res 1997 12(S1):T678.
36. Gundberg CM, Nieman SD, Abrams S, et al: Vitamin K status and bone health: an analysis of methods for the determination of "undercarboxylated" osteocalcin. J Clin Endocrinol Metab 1998, in press.
37. Salo J, Lehenkari P, Mulari M, et al: Removal of osteoclast bone resorption products by transcytosis. Science 1997;276:270.
38. Page AE, Hayman AR, Andersson LMB, et al: Degradation of bone matrix proteins by osteoclast cathepsins. Internat J Biochem 1993;25:5450.
39. Baumgrass R, Williamson MK, Price PA: Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S. J Bone Min Res 1997;12:447.
40. Baumgrass R, Felsenberg D, Price PA: The cross-reactivities of cathepsin generated bone GLA protein-fragments in different immunoassays. J Bone Min Res 1995;10:S339(Abstract).
41. Novak JF, Hayes JD, Nishimoto SK: Plasmin-mediated proteolysis of osteocalcin J Bone Min Res 1997;12:1035.
42. Thiede MA, Smock SL, Petersen DN, et al: Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakyocytes and peripheral blood platelets. Endocrinology 1994;135:929.
43. Gundberg CM, Hauschka PV, Lian JB, et al: Osteocalcin: Isolation, characterization and detection, in: Moldave K (ed) Methods in Enzymology. New York, Academic Press, 1984, p 516.
44. Price PA, Nishimoto SK: Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 1980;77:2234.
45. Delmas PD, Christiansen C, Mann KG, et al: Bone gla protein (osteocalcin)assay standardization report. J Bone Min Res 1990;5:5.
46. Masters PW, Jones RG, Purves DA, et al: Commercial assays for serum osteocalcin give clinically discordant result. Clin Chem 1994;40:358.
47. Garnero P, Grimaux M, Demiaux B, et al: Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Min Res 1992;7:1389.
48. Jaouhari J, Schiele F, Dragacci S, et al: Avidin-biotin enzyme immunoassay of osteocalcin in serum or plasma. Clin Chem 1992;38:1968.
49. Hosoda K, Eguchi H, Nakamoto T, et al: Sandwich immunoassay for intact human osteocalcin. Clin Chem 1992;38:2233.
50. Monaghan DA, Power MJ, Fottrell PF: Sandwich enzyme immunoassay of osteocalcin in serum with use of an antibody against human osteocalcin. Clin Chem 1993;39:942.
51. Colford J, Sailer D, Langman C: Five osteocalcin assays compared: tracer specificity, fragment interference and calibration. Clin Chem 1997;43:1240.
52. Hellman J, Kakonen S-M, Matikainen M-T, et al: Epitope mapping of nine monoclonal antibodies against osteocalcin: Combinations into two-site assays affect both assay specificity and sample stability. J Bone Miner Res 1996;11:1165.
53. Parviainen M, Kuronen I, Kokko H, et al: Two-site enzyme immunoassay for measuring intact human osteocalcin in serum. J Bone Min Res 1994;9:347.
54. Kuronen I, Kokko H, Parviainen M: Production of monoclonal and polyclonal antibodies against human osteocalcin sequences and development of a two-site ELISA for intact human osteocalcin. J Immunol Methods 1993;163:223.
55. Deftos LJ, Wolfert RL, Hill CS, et al: Two-site assays of bone Gla protein (osteocalcin) demonstrate immunochemical heterogeneity of the intact molecule. Clin Chem 1992;38:2318.
56. Diego EMD, Guerrero R, Piedra Cdl: Six osteocalcin assays compared. Clin Chem 1994;40:2071.
57. Souberbielle JC, Marque D, Bonnet P, et al: Simple method to evaluate specificity of osteocalcin immunoassays. Clin Chem 1997;43:1663.
58. Blumsohn A, Hannon RA, Eastell R: Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem 1995;41:318.
59. Minisola S, Rosso R, Romangnoli E, et al: Serum osteocalcin and bone mineral density at various skeletal sites: A study performed with three different assays. J Lab Clin Med 1997;129:422.
60. Gertz BJ, Shao P, Hanson DA, et al: Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Min Res 1994;9:135.
61. Beck-Jensen JE, Kollerup G, Sorenson HA, et al: A single measurement of biochemical markers of bone turnover has limited utility in the individual person. Scand J Clin Lab Invest 1997;57:351.
62. Panteghini M, Pagani F: Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 1995;55:609.
63. Farrugia W, Melick RA: Metabolism of osteocalcin. Calcif Tissue Int 1986; 39:234-238.
64. Price PA, Williamson MK, Lothringer JW: Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981;256:12760.
65. Gundberg CM, Markowitz ME, Mizruchi M, et al: Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985;60:736.
66. Nielsen H, Brixen K, Kassem M, et al: Diurnal rhythm in serum osteocalcin: relation to sleep, growth hormone, and PTH (1-84). Calcif Tissue Int 1991;49:373.
67. Dumon JC, Wantier H, Mathieu, et al: Technical and clinical validation of a new immunoradiometric assay for human osteocalcin. European J Endocrin 1996;135:231.
68. Rosenquist C, Quist P, Bjarnason N, et al: Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995;41:1439.
69. Power MJ, O'Dwyer B, Breen E, et al: Osteocalcin concentrations in plasma prepared with different anticoagulants. Clin Chem 1991;37:281.
70. Cole DEC, Carpenter TO, Gundberg CM: Serum osteocalcin concentrations in children with metabolic bone disease. J Ped 1985;106:770.
71. Delmas PD, Glorieux FH, Delvin EE, et al: Perinatal serum bone gla-protein and vitamin D metabolites in preterm and fullterm neonates. J Clin Endocrinol Metab 1987;65:588.
72. Catherwood B, Marcus R, Madvig P, et al: Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects. Bone 1985;6:9.
73. Delmas PD, Stenner D, Wahner HW, et al: Increase in serum bone g-carboxyglutamic acid protein with aging in women. J Clin Invest 1983;71:1316.
74. Epstein S, McClintock R, Bryce G, et al: Differences in serum bone gla protein with age and sex. The Lancet Feb 1984;11:307.
75. Galli M, Caniggia M: Osteocalcin in normal adult humans of different sex and age. Horm Metab Res 1984;17:165.
76. Tarallo P, Henny J, Fournier B, et al: Plasma osteocalcin: biological variations and reference limits. Scand J Clin Lab Invest 1990;50:649.
77. Johansen JS, Thomsen K, Christiansen C: Plasma bone Gla protein concentrations in healthy adults. Dependence on sex, age, and glomerular filtration. Scand J Clin Lab Invest 1987;47:345.
78. Nilas L, Christiansen C: Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987;65:697.
79. 2D levels in renal disease. Kidney Int 1983;24:104.
80. Delmas PD, Wilson DM, Mann KG, et al: Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab 1983;57:1028.
81. Malluche HH, Faugere M-C, Fanti P, et al: Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984;26:869.
82. Friedman A, Heiliczer J, Gundberg C, et al: Serum osteocalcin concentrations in children with chronic renal insufficiency who are not undergoing dialysis. J Ped 1990;116:555.
83. Lian JB, Gundberg CM: Biochemical considerations and clinical applications. Clin Ortho Related Res 1988;226:267.
84. Power MJ, Fottrell PF: Osteocalcin: diagnostic methods and clinical applications. Crit Rev in Clin Lab Sci 1991;28:287.
85. Hauschka PV, Lian JB, Cole DE, et al: Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990.
86. Delmas PD, Demiaux B, Malaval L, et al: Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue Int 1986;38:60.
87. Slovik RM, Gundberg CM, Neer RM, et al: Clinical evaluation of bone turnover by serum osteocalcin measurements. J Clin Endocrinol Metab 1984;59:228.
88. Ebeling PR, Atley LM, Guthrie JR, et al: Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996;81:3366.
89. Garnero P, Sornay-Rendu E, Chapuy M-C, et al: Increased bone turnover in late postmenopausal women is a major deteminant of osteoporosis. J Bone Min Res 1996;11:337.
90. Dresner-Pollak R, Seibel MJ, Greenspan S et al: Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 1996;59:328.
91. Rosen C, Chesnut CH III, Mallinak NJS: The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 1997;82:1904.
92. Delmas PD, Wahner HW, Mann KG, et al: Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med 1983;102:470.
93. Delmas PD, Stenner D, Heinz W, et al: Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest 1983;71:1316.
94. Yasumura S, Aloia JF, Gundberg CM, et al: Serum osteocalcin and total body calcium in normal pre-and postmenopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab 1987;64:681.
95. Akesson K, Ljunghall S, Gardsell P, et al: Serum osteocalcin and fracture susceptibility in elderly women. Calcif Tissue Int 1993;53:86.
96. Akesson K, Vergnaud P, Gineyts E, et al: Impairment of bone turnover in elderly women with hip fracture. Calcif Tissue Int 1993;53:162-169.
97. Akesson K, Vergnaud P, Delmas PD, et al: Serum osteocalcin increases during fracture healing in elderly women with hip fracture. Bone 1995;6:427.
98. Harris ST, Gertz BJ, Genant HK, et al: The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrinol Metab 1993;76:1399.
99. Stock JL, Coderre JA, Mallette LE: Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab 1985;61:595.
100. Pak CY, Sakhaee K, Gallagher C, et al: Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis. J Bone Min Res 1986;1:563.
101. Hodges SJ, Pilkington MJ, Stamp TCB, et al: Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991;12:387.
102. Rosen NH, Maitland LA, Suttie JW, et al: Vitamin K and maintenance of skeletal integrity in adults. Amer J Med 1993;94:62.
103. Lafforque P, Daver L, Monites JR, et al: Bone mineral density in patients given oral vitamin K antagonists. Revue Du Rhumatisme 1997;64:249.
104. Philip WJU, Martin JC, Richardson JM, et al: Decreased axial and peripheral bone density in patients taking long-term warfarin. QJ Med 1995;88:635.
105. Monreal M, Olive A, Lafozz E, et al: Heparins, coumarin, and bone density. The Lancet 1995;338:706.
106. Jamal S, Milani G, Lipschutz R, et al: The therapeutic use of warfarin does not influence post-menopausal osteoporosis. J Bone Min Res 1997;12(S1):T512.
107. Price PA, Williamson MK, Lothringer JW: Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981;256:12760.
108. Sokoll L, O'Brien ME, Camilo ME, et al: Undercarboxylated osteocalcin: development of a method to determine vitamin K status. Clin Chem 1995;41:1121.
109. Plantalech, L, Guillaumont M, Vergnaud P, et al: Impairment of gamma carboxylation of circulating osteocalcin (bone Gla protein) in elderly women. J Bone and Mineral Res 1991;6(1):1211.
110. Sokoll LJ, Sadowski JA: Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr 1996;63:566.
111. Szulc P, Chapuy M-C, Meunier P, et al: Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769.
112. Vergnaud P, Garnero P, Meunier PJ, et al: Undercarboxylated osteocalcin measured with a specific immunoassy predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol 1997;82:719.